Fundraising Fox

Tevard Biosciences

Boston, US · 29 employees on LinkedIn · 3 known investors

Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.

Biotech

Founders & leadership

HLHarvey Lodish
Harvey Lodish
DFDaniel Fischer
Daniel Fischer
WLWarren Lammert
Warren Lammert

Investors · 3

CWRU Technology VenturesCleveland · $50K – $250K
Good Growth CapitalCharleston
Lauder PartnersLos Altosvia Gary Lauder · inferred

Competitors · 1

by search overlap
Bioworld16 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Tevard Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Tevard Biosciences do?
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.
Who founded Tevard Biosciences?
Tevard Biosciences was founded by Harvey Lodish, Daniel Fischer, Warren Lammert.
Who are Tevard Biosciences's investors?
Tevard Biosciences's investors include CWRU Technology Ventures, Good Growth Capital, Lauder Partners.
Where is Tevard Biosciences headquartered?
Tevard Biosciences is headquartered in Boston, US.